Related Experiment Video
Updated: Jul 10, 2026
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Dyslipidemia in Pulmonary Tuberculosis Patients Attending Nsawam Adoagyiri Municipal Hospital: Pre- and
Prince Agyeman1, Nixon Ntiri Somuah2, Yussif Adams3
1Department of Medical Laboratory Science KAAF University College Accra Ghana.
Background:
Tuberculosis (TB) remains a significant public health problem in Ghana, with high morbidity and mortality rates. Persons with TB are at risk of adverse cardiovascular disease with hyperlipidemia being a major risk factor. The standard treatment for pulmonary TB includes a combination of anti-tuberculosis drugs such as Rifampicin, Isoniazid, pyrazinamide, and ethambutol which have been associated with changes in lipid profile that could increase the risk of cardiovascular disease. Despite the existence of the links between cholesterol and TB, it is not clear to what extent the treatment of the disease affects lipid indicators in patients with TB, particularly in Ghana. This study, therefore, sought to investigate any differences in the concentration of lipid profile in Pulmonary Tuberculosis patients in Nsawam Adoagyiri Municipality vis-sa-vis pre- and post-anti-tuberculosis treatment.
Methods:
A cross-sectional survey involving 210 participants was conducted in Nsawam-Adoagyiri Municipal Hospital, in the Eastern Region of Ghana. Data were analyzed using STATA version 17. Categorical variables were presented as numbers (percentages). Continuous variables with normal distribution were expressed as mean ± standard deviation. Inferential statistics were explored using paired t-test. A p < 0.05 was considered statistically significant.
Results:
The overall dyslipidemia pre- and post-tuberculosis treatment are 69.0% (145/210) and 77.6% (163/210) respectively. The mean Total Cholesterol and LDL increased significantly after the patient had completed the anti-tuberculosis treatment (p < 0.001). However, there were no significant difference in the mean triglycerides (TG) and HDL levels before and after treatment.
Conclusion:
These findings suggest that dyslipidemia is quite prevalent among TB patients attending the Nsawam Government Hospital, which may have a negative effect on their health and general well-being. There is a significant difference in the lipid profile results of the participants' overall before and after the TB therapy. Anti-TB treatment needs to develop more advanced recommendations that take patients' lipid levels into account in order to improve the outcomes for TB patients.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Tuberculosis